Senior insider sale
Chief Executive Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$180.2K
26.49K shares
What this filing means
BARROW ROBERT plans to sell 26.49K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $180.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2025ACC: 0001950047-25-004601
DirectorOfficer· Chief Executive Officer
Since Jan 2022
26.49K
Shares to sell
$180.2K
Approx. market value
26.49K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Compensation
6/25/2025
26.49KTotal acquired26.49K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2025 | Restricted stock vesting under a registered plan Compensation | 26.49K | — |
| Total | 26.49K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
26.49K
Market value
$180.2K
6/25/2025
Total
Units
26.49K
Value
$180.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/25/2025 | 26.49K | $180.2K | NASDAQ | Planned |
| Total | 26.49K | $180.2K | ||